Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.70 is 78% below its 5-year average of 3.16, near the low end of its 5-year range (0.70–5.24).
As of the fiscal period ended Tuesday, June 30, 2026. 52.95% below its 12-month average of 1.48.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.70.
QUICK RATIO (ACID-TEST)
0.70
QUICK RATIO (ACID-TEST) AVG TTM
1.48
QUICK RATIO (ACID-TEST) AVG 3Y
2.06
QUICK RATIO (ACID-TEST) AVG 5Y
3.16
QUICK RATIO (ACID-TEST) AVG 10Y
3.41
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-52.95%
CURRENT VS 3Y AVG
-66.15%
CURRENT VS 5Y AVG
-77.91%
CURRENT VS 10Y AVG
-79.53%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
-75.04%
vs the sector median at left
BeyondSpring Inc.
Market Cap
$32.32M
Quick Ratio (Acid-Test)
0.70
TTM Avg
1.48
3Y Avg
2.06
5Y Avg
3.16
Market Cap
$32.31M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.16
3Y Avg
0.31
5Y Avg
0.42
Market Cap
$31.36M
Quick Ratio (Acid-Test)
1.26
TTM Avg
1.70
3Y Avg
1.87
5Y Avg
1.80
Market Cap
$33.42M
Quick Ratio (Acid-Test)
2.19
TTM Avg
3.38
3Y Avg
4.17
5Y Avg
5.03
Market Cap
$33.52M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$30.92M
Quick Ratio (Acid-Test)
5.81
TTM Avg
22.07
3Y Avg
14.94
5Y Avg
12.78
Market Cap
$35.89M
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.82
3Y Avg
0.89
5Y Avg
0.96
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $32.32M | 0.70 | 1.48 | 2.06 | 3.16 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 0.18 | 0.16 | 0.31 | 0.42 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 1.26 | 1.70 | 1.87 | 1.80 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | 2.19 | 3.38 | 4.17 | 5.03 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 11.47 | 9.93 | 10.68 | 16.03 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 5.81 | 22.07 | 14.94 | 12.78 |
| CervoMed Inc. (CRVO)vs › | $30.65M | 8.57 | 7.97 | 5.03 | 6.79 |
| Accuray Incorporated (ARAY)vs › | $35.89M | 0.74 | 0.82 | 0.89 | 0.96 |
| DocGo Inc. (DCGO)vs › | $36.05M | 1.66 | 2.38 | 2.35 | 2.72 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 5.12 | 5.39 | 5.72 | 7.97 |
Quick Ratio
0.70
Excludes inventory
Current Ratio
0.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.70 |
| 2026-03-31 | 1.09 |
| 2025-12-31 | 1.54 |
| 2025-09-30 | 1.89 |
| 2025-06-30 | 2.19 |
| 2025-03-31 | 2.49 |
| 2024-12-31 | 2.60 |
| 2024-09-30 | 2.60 |
| 2024-06-30 | 1.82 |
| 2024-03-31 | 1.82 |
| 2023-12-31 | 2.31 |
| 2023-09-30 | 2.31 |
| 2023-06-30 | 3.78 |
| 2023-03-31 | 3.78 |
| 2022-12-31 | 5.24 |
| 2022-09-30 | 5.24 |
| 2022-06-30 | 5.02 |
| 2022-03-31 | 5.02 |
| 2021-12-31 | 4.96 |
| 2021-09-30 | 5.10 |
| 2021-06-30 | 4.82 |
| 2021-03-31 | 7.47 |
| 2020-12-31 | 8.24 |
| 2020-09-30 | 2.78 |
| 2020-06-30 | 3.80 |
| 2020-03-31 | 2.44 |
| 2019-12-31 | 4.06 |
| 2019-09-30 | 3.61 |
| 2019-06-30 | 0.10 |
| 2019-03-31 | 0.13 |
| 2018-12-31 | 0.28 |
| 2018-09-30 | 1.36 |
| 2018-06-30 | 4.36 |
| 2018-03-31 | 4.01 |
| 2017-12-31 | 6.75 |
| 2017-09-30 | 14.01 |
| 2017-06-30 | 15.82 |
| 2017-03-31 | 28.84 |
| 2016-12-31 | 5.64 |
| 2016-09-30 | 5.57 |
| 2016-06-30 | 2.56 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 8.34 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
